X Square Capital LLC Acquires Shares of 23,025 Semler Scientific, Inc. (NASDAQ:SMLR)

X Square Capital LLC bought a new stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) in the 4th quarter, HoldingsChannel reports. The fund bought 23,025 shares of the company’s stock, valued at approximately $1,243,000.

Other hedge funds also recently made changes to their positions in the company. Verition Fund Management LLC purchased a new stake in Semler Scientific during the third quarter worth about $251,000. Principal Financial Group Inc. increased its stake in shares of Semler Scientific by 633.1% during the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock worth $6,074,000 after purchasing an additional 97,144 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Semler Scientific by 10.5% in the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after purchasing an additional 12,964 shares during the period. IFP Advisors Inc purchased a new position in Semler Scientific in the fourth quarter valued at approximately $54,000. Finally, Jane Street Group LLC grew its holdings in Semler Scientific by 72.3% during the third quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock valued at $400,000 after purchasing an additional 7,126 shares during the period. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Stock Down 6.7 %

NASDAQ SMLR opened at $36.92 on Friday. The company has a market cap of $354.32 million, a PE ratio of 7.52 and a beta of 1.33. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $81.56. The firm’s 50-day simple moving average is $46.02 and its two-hundred day simple moving average is $44.53.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Analysts Set New Price Targets

Separately, Lake Street Capital boosted their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, January 24th.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.